Alaunos Therapeutics, Inc. (TCRT)
$3.03+188.57%Close
BUYRECOVERY · day 1
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $7M
- Beta
- -0.97
- P/E (TTM)
- -1.55
- Short % float
- 0.52%
- Days to cover
- 1.0
- SI change
- +60.3%
- 1W
- +309.46%
- 1M
- +103.36%
- vs SPY 1W
- +309.60%
- vs SPY 1M
- +100.85%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
ANALYST & RATINGS
LOADING…Loading analyst data…
Company news
FAQ
- What is LOPJLB’s current signal on TCRT?
- LOPJLB’s latest quantitative signal on Alaunos Therapeutics, Inc. (TCRT) is BUY in a RECOVERY regime. Signals are updated daily.
- What market regime is TCRT in?
- Alaunos Therapeutics, Inc. (TCRT) is currently classified in the RECOVERY HMM market regime on LOPJLB.
- What does Alaunos Therapeutics, Inc. (TCRT) do?
- Alaunos Therapeutics, Inc. is an oncology company in the clinical trial phase, specializing in the creation of adoptive T-cell receptor (TCR) engineered therapies. Their pipeline includes a TCR Library, currently undergoing Phase I/II clinical trials, which comprises ten T-cell receptors designed to target mutated KRAS, TP53, and EGFR in various cancers such as non-small cell lung, colorectal, …